Elizabeth Cathcart-Rake

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
To the Editor: The importance of submitting data of clinical response to epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) in patients with uncommon EGFR mutations has been encouraged. 1 In view of this, we present two cases of a rare EGFR mutation that appears to confer resistance to TKIs. Case 1, a 56-year-old Afro-Caribbean male(More)
  • 1